During the past decade, Karlstad Central Hospital conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 6 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Karlstad Central Hospital" #1 sponsor was "Karolinska Institutet" with 5 trials, followed by "Lund University Hospital" with 5 trials sponsored, "Karolinska University Hospital" with 4 trials sponsored, "Uppsala University" with 4 trials sponsored and "Örebro County Council" with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karlstad Central Hospital" #1 collaborator was "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 3 trials as a collaborator, "Lund University" with 3 trials as a collaborator, "Swedish Breast Cancer Group" with 3 trials as a collaborator, "Uppsala University Hospital" with 3 trials as a collaborator and "Karlstad Central Hospital" with 2 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 65 trials.

According to Clinical.Site data, the most researched conditions in "Karlstad Central Hospital" are "Breast Cancer" (4 trials), "Coronary Artery Disease" (3 trials), "Out-of-hospital Cardiac Arrest" (3 trials), "Anesthesia" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Karlstad Central Hospital" in a lesser frequency.

Most popular intervention types in "Karlstad Central Hospital" are "Drug" (26 trials), "Procedure" (10 trials), "Other" (6 trials), "Device" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Rituximab" (2 trials), "A PAD-specific smartphone application (e-intervention) developed for patients with Peripheral Artery Disease" (1 trials), "ACEI" (1 trials) and "ARB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Karlstad Central Hospital" are 44 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Karlstad Central Hospital". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Karlstad Central Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Karlstad Central Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".